Search

Lameness is a common health and welfare problem in sows. Little has been published about behavioral changes in lame sows. Ketoprofen is an effective non-steroidal anti-inflammatory drug used to treat non-infectious locomotor disorders in pigs. The aim of this study was to determine the effect of lameness and lameness-related pain on the behavior of sows. To evaluate this effect, we studied whether pain alleviation with ketoprofen and clinical relief of lameness were associated with changes in behavior. We allocated randomly 13 lame, early pregnancy sows in three treatment groups receiving either ketoprofen 4 mg/kg, ketoprofen 2 mg/kg (these two groups were pooled for statistical analyses) or placebo. The animals were treated orally for 5 days and lameness scored before and on the last day of the treatment. Lameness was assessed with a 5-grade scoring system and behavior by scan sampling method. A clinically healthy, non-lame control sow was paired with each lame sow and they were examined the same way as lame sows but received no treatment. Lame sows were more passive, they lay more and stood and explored pen fixtures less than the control sows before treatment. After 5-days treatment, placebo-treated sows were in contact with the wall and lying more often when compared to control sows. Ketoprofen-treated sows were more seldom in contact with the wall and exploring bedding more often than placebo-treated sows. Placebo sows tended also to move and explore bedding less than control sows. Lameness had been relieved in altogether 7 out of 13 sows on day 5: six out of nine ketoprofen-medicated sows and one out of four placebo-treated sows. The behaviour of sows with relieved lameness did not differ from that of control sows on day 5. Sows with non-relieved lameness were in contact with the wall and lying more and moving and standing less than control sows. When compared to control sows, sows with non-relieved lameness tended to be more passive. When compared to sows with relieved lameness, sows with non-relieved lameness showed a tendency to be in contact with the wall more often. Our study showed that lameness reduces the activity of sows and affects their position in the pen. Passive behavior seemed at least partly be due to pain and lameness relief was associated with normalization of the behavior.

The aim of this study was to estimate the prevalence of serum antibodies to Actinobacillus pleuropneumoniae (APP) in Finnish farmed wild boars and to evaluate basic risk factors for seropositivity of the agent. A sampling frame was compiled based on the national record of wild boar farmers (n = 117), and 26 herds were included in the study. Serum samples (n = 206) were obtained from all animals slaughtered from these herds during the 2007-2008 period. Indirect enzyme-linked immunosorbent assay techniques were used to detect the possible presence of antibodies toward 12 serotypes of APP. Altogether, 1,442 analyses were performed, out of which 35 (2.4%) exceeded the positive cut-off value. Correspondingly, 26 of the pigs (12.6%) were found to be seropositive for any serotype of APP. The apparent animal prevalence of the cross-reacting APP serotypes 1, 9, and 11 was 3.9% (95% confidence interval [CI] 1-7%); it was 0.5% (CI 0-1%) for serotype 2; 3.4% (CI 1-6%) for serotypes 3, 6, and 8; 7.3% (CI 4-11%) for serotypes 4 and 7; 0.5% (CI 0-1%) for serotype 10; and 1.5% (CI 0-3%) for serotype 12. No antibodies against serotype 5s were detected. The apparent farm prevalence of APP serotypes 1,9, and 11 was 15.4% (CI 2-29%); that of serotype 2 was 3.8% (CI 0-11%); that of serotypes 3, 6, and 8 was 11.5% (CI 0-24%); that of serotypes 4 and 7 was 34.6% (CI 16-53%); that of serotype 10 was 3.8% (CI 0-11%); and that of serotype 12 was 7.7% (CI 0-18%). In conclusion, the prevalence of serum antibodies to different APP serotypes was low in farmed wild boar. Risk factor analysis did not reveal any significant animal- or herd-level risk factors for seropositivity of the agent.

The aim of this study was to estimate in farmed European wild boars the prevalence of and risk factors associated with a range of common porcine viral and bacterial infections, namely, porcine parvovirus (PPV), porcine circovirus type 2 (PCV2), swine influenza virus (SIV), Aujeszky’s disease virus (ADV), classical swine fever virus (CSFV), swine vesicular disease virus (SVDV), coronavirus causing transmissible gastroenteritis (TGEV), porcine reproductive and respiratory syndrome virus (PRRSV), Mycoplasma hyopneumoniae, Lawsonia intracellularis, Brucella spp., and Leptospira spp. A sampling frame was compiled based on a national record of wild boar farmers, and 32 farms were surveyed. Serological screening was carried out on 303 samples from animals slaughtered between 2005 and 2008, and random-effect logistic regression models were developed for pathogens with a ‘non-zero’ prevalence. The apparent animal prevalence for PPV, PCV2, and L. intracellularis was 46.5% (95% confidence interval [CI] 41–52%), 51.1% (95% CI 45–57%) and 59.2% (95% CI 54–65%), respectively. Apparent farm seroprevalence rates for PPV, PCV2 and Lawsonia intracellularis were 56.3% (95% CI, 39–73%), 21.9% (95% CI, 8–36%) and 78.1% (95% CI, 64–92%), respectively. No antibodies were detected against SIV, ADV, CSFV, SVDV, TGEV, PRSSV, Leptospira spp., Brucella spp., or M. hyopneumoniae. Increasing herd size, proximity to dense populations of domestic swine and later sampling times within the survey period were found to be risk factors. Overall, the seroprevalence of these pathogens in farmed wild boar was similar to that in the farmed domestic pig population in Finland. However, it is possible that the rearing of wild boars in fenced estates may predispose them to particular infections, as reflected in higher antibody titres.

The efficacy of ketoprofen in the treatment of non-infectious lameness in sows was examined in a double-blinded study. Two dose rates of oral ketoprofen were compared to placebo treatment over five consecutive days. Lameness was assessed with a five-grade scoring system prior to and on the last day of the treatment. The rate of treatment success was 54.3% for the ketoprofen 4 mg/kg group ( n = 46), 53.2% for the ketoprofen 2 mg/kg group ( n = 47) and 20.8% for the pigs in the placebo group ( n = 48). The difference between both ketoprofen groups and the placebo group was significant ( P = 0.001), but there was no difference between the two ketoprofen groups ( P = 0.78). Oral ketoprofen was well tolerated and no adverse events were observed. As lameness is a very common problem in sows, oral ketoprofen appeared to be a practical way to alleviate pain and improve the welfare of sows.

The prevalence of lameness among 646 sows and gilts in 21 selected herds was determined; 8.8 per cent of the animals were lame and the most common clinical diagnoses were osteochondrosis, infected skin lesions and claw lesions. The lame animals had higher serum concentrations of haptoglobin and C-reactive protein than the sound animals. Animals housed on slatted floors had twice the odds of being lame and 3.7 times the odds of being severely lame than animals housed on solid floors. Yorkshire pigs had 2.7 times the odds of being lame than Landrace or crossbred animals. Higher parity and the use of roughage decreased the odds of the sows not becoming pregnant; however, lameness was not a risk factor for non-pregnancy.

Background In Finland, the most important internal parasites in domestic pigs are nematode Ascaris suum and coccidia Isospora suis. As the environmental conditions and management practices in wild boar (Sus scrofa) outdoor farming are suitable for parasites during most seasons, we wanted to explore the parasite burden of wild boars in Finland. This kind of research has not been carried out earlier in our country. Economical losses caused by internal parasites, especially ascarids, are mainly due to reduced daily weight gain and feed conversion ratio [1].